Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yvette Jee"'
Autor:
Maryam Shojaei, Amir Shamshirian, James Monkman, Laura Grice, Minh Tran, Chin Wee Tan, Siok Min Teo, Gustavo Rodrigues Rossi, Timothy R. McCulloch, Marek Nalos, Maedeh Raei, Alireza Razavi, Roya Ghasemian, Mobina Gheibi, Fatemeh Roozbeh, Peter D. Sly, Kirsten M. Spann, Keng Yih Chew, Yanshan Zhu, Yao Xia, Timothy J. Wells, Alexandra Cristina Senegaglia, Carmen Lúcia Kuniyoshi, Claudio Luciano Franck, Anna Flavia Ribeiro dos Santos, Lucia de Noronha, Sepideh Motamen, Reza Valadan, Omolbanin Amjadi, Rajan Gogna, Esha Madan, Reza Alizadeh-Navaei, Liliana Lamperti, Felipe Zuñiga, Estefania Nova-Lamperti, Gonzalo Labarca, Ben Knippenberg, Velma Herwanto, Ya Wang, Amy Phu, Tracy Chew, Timothy Kwan, Karan Kim, Sally Teoh, Tiana M. Pelaia, Win Sen Kuan, Yvette Jee, Jon Iredell, Ken O’Byrne, John F. Fraser, Melissa J. Davis, Gabrielle T. Belz, Majid E. Warkiani, Carlos Salomon Gallo, Fernando Souza-Fonseca-Guimaraes, Quan Nguyen, Anthony Mclean, Arutha Kulasinghe, Kirsty R. Short, Benjamin Tang
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
PurposeRobust biomarkers that predict disease outcomes amongst COVID-19 patients are necessary for both patient triage and resource prioritisation. Numerous candidate biomarkers have been proposed for COVID-19. However, at present, there is no consen
Externí odkaz:
https://doaj.org/article/90cb309064c14456837451531198b0a2
Autor:
Timothy J. Wells, Ya Wang, Jon Iredell, Amy Phu, Sally Teoh, Win Sen Kuan, Yanshan Zhu, Melissa J. Davis, Timothy McCulloch, Majid Ebrahimi Warkiani, Tiana M Pelaia, Yao Xia, Chin Wee Tan, Timothy Kwan, Lucia de Noronha, Velma Herwanto, Reza Alizadeh-Navaei, Amir Shamshirian, Carmen Lúcia Kuniyoshi Rebelatto, John F. Fraser, Tracy Chew, Reza Valadan, Liliana Lamperti, Kenneth J. O'Byrne, Marek Nalos, Gabrielle T. Belz, Yvette Jee, Quan Nguyen, Keng Yih Chew, Maryam Shojaei, Anthony S. McLean, Benjamin Tang, Alexandra Cristina Senegaglia, Carlos Salomon Gallo, Laura F. Grice, Ben Knippenberg, Arutha Kulasinghe, Kirsty R. Short, Felipe Zuñiga, Omolbanin Amjadi, Sepideh Motamen, Estefania Nova-Lamperti, Rajan Gogna, Anna Flavia Ribeiro dos Santos, Minh Tran, Karan Kim, Fernando Souza-Fonseca-Guimaraes, James Monkman, Gustavo Rodrigues Rossi, Gonzalo Labarca, Esha Madan, Claudio Luciano Franck
BackgroundRobust biomarkers that predict disease outcomes amongst COVID-19 patients are necessary for both patient triage and resource prioritisation. Numerous candidate biomarkers have been proposed for COVID-19. However, at present, there is no con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b43dd230438b36df1bcefeac6c9ac27b
https://doi.org/10.1101/2021.10.29.21265555
https://doi.org/10.1101/2021.10.29.21265555
Publikováno v:
Chest. 148:442A